Solifenacin is known by several brand names, with Vesicare being the most prominent [1].
What other drugs are similar to Solifenacin?
Solifenacin is a muscarinic antagonist used to treat overactive bladder symptoms like urinary incontinence, urgency, and frequency. Other drugs in this class, known as anticholinergics, include:
* Oxybutynin (Ditropan) [2]
* Tolterodine (Detrol) [2]
* Darifenacin (Enablex) [2]
* Trospium (Sanctura) [2]
* Fesoterodine (Toviaz) [2]
These medications work by relaxing the bladder muscle, allowing it to hold more urine and reducing the sudden urges to urinate [2].
When does Solifenacin patent expire?
The patent expiry for Solifenacin can vary depending on specific patents and regions. For the United States, the primary patents for Solifenacin have expired, allowing for the availability of generic versions. DrugPatentWatch.com tracks patent information for various medications, including Solifenacin [3].
Are there generic versions of Vesicare?
Yes, generic versions of Vesicare, the brand name for Solifenacin, are available. The availability of generics typically follows the expiry of primary patents [3].
What are the side effects of Solifenacin?
Common side effects associated with Solifenacin can include dry mouth, constipation, blurred vision, and indigestion [1]. Less common but more serious side effects may occur [1].
How does Solifenacin work?
Solifenacin functions by blocking the action of acetylcholine on muscarinic receptors in the bladder's smooth muscle. This blockade relaxes the detrusor muscle, increasing bladder capacity and reducing involuntary bladder contractions, which alleviates symptoms of overactive bladder [4].
What conditions does Solifenacin treat?
Solifenacin is prescribed to manage the symptoms of overactive bladder (OAB), which include a sudden, strong urge to urinate, frequent urination, and urge incontinence [1].
What are the risks of taking Solifenacin?
Patients should be aware of potential risks, especially those with certain medical conditions. Solifenacin may not be suitable for individuals with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. It can also worsen symptoms in patients with severe constipation or those with certain gastrointestinal conditions [1].
Where can I find more information on Solifenacin patents?
Information on Solifenacin's patent status, including expiry dates and potential challenges, can be found on resources like DrugPatentWatch.com [3].
---
Sources:
[1] https://www.nhs.uk/medicines/solifenacin/
[2] https://www.nhs.uk/medicines/tolterodine/
[3] https://drugpatentwatch.com/
[4] https://www.rxlist.com/consumervesicaresolifenacin/drugs/drug-summary.htm